IP Verse

Modified Release Formulation Of Lacosamide - EP2496220

The patent EP2496220 was granted to Lupin on Oct 16, 2019. The application was originally filed on Nov 3, 2010 under application number EP10790595A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2496220

LUPIN
Application Number
EP10790595A
Filing Date
Nov 3, 2010
Status
Opposition Rejected
Jul 15, 2022
Grant Date
Oct 16, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEJul 16, 2020CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (22) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5654301
INTERNATIONAL-SEARCH-REPORTDE102008059155
INTERNATIONAL-SEARCH-REPORTUS2007043120
INTERNATIONAL-SEARCH-REPORTWO2006036007
OPPOSITIONDE102008059155
OPPOSITIONJP2006124385
OPPOSITIONUS2005277579
OPPOSITIONUS2006100157
OPPOSITIONUS2006135437
OPPOSITIONUS2006165745
OPPOSITIONUS2007042969
OPPOSITIONUS2007043120
OPPOSITIONUS2007071819
OPPOSITIONUS4369172
OPPOSITIONUS5773475
OPPOSITIONUS6627223
OPPOSITIONWO2006036007
OPPOSITIONWO2007120485
OPPOSITIONWO2008086492
OPPOSITIONWO2009146325
OPPOSITIONWO2010009433
OPPOSITIONWO2010018408

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Vimpat (lacosamide) Tablets and Injection", INTERNET CITATION, (20081001), INTERNET CITATION, URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022253lbl.pdf, (20121112), XP055043938-
OPPOSITION- BEYREUTHER et al., "Lacosamide: A Review of Preclinical Properties", CNS Drug Reviews, (20070000), vol. 13, no. 1, pages 21 - 42, XP055788109-
OPPOSITION- Craig Paul N, "Synthesis of ion exchange resins", Annals of the New York academy of sciences, (19530101), pages 67 - 78, XP055788112-
OPPOSITION- "Ion-exchange resin", Encyclopaedia Britannica, URL: https://www.britannica.com/ science /ion- exchanqe-resin-
OPPOSITION- Ranade Vasant V, Hollinger Mannfred A., Drug Delivery Systems. Second Edition. Excerpt, CRC Press Pharmacology & Toxicology Series, (20040101), pages 167 - 167, XP055788117-
OPPOSITION- Wikipedia, "Ion-exchange resin. Wikipedia.", Wikipedia, (20200715), pages 1 - 6, URL: https://en.wikipedia.orq/wiki/lon-exchanqe resin, (20210322), XP055788120-
OPPOSITION- LI et al., "The use of hypromellose in oral drug delivery", JPP, (20050000), vol. 57, doi:10.1211/0022357055957, pages 533 - 546, XP002693776

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents